Scientists at deCODE genetics (Nasdaq: DCGN) and academic colleagues from the United States today report the discovery of a common genetic variant that confers increased risk of myocardial infarction (MI), or heart attack.
deCODE genetics (Nasdaq: DCGN) today announced the launch of deCODE MI ™, a reference laboratory test for variations in the genome (called SNPs) that the company has associated with increased risk of myocardial infarction, or heart attack.